Bank of America’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bank of America’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-452,808	Closed	-$24.4M	–	7548
2017 Q4	$24.4M	Sell	452,808 -71,561	-14%	-$3.92M	﹤0.01%	1649
2017 Q3	$29.9M	Buy	524,369 +125,406	+31%	+$7.34M	﹤0.01%	1545
2017 Q2	$24M	Sell	398,963 -76,095	-16%	-$4.33M	﹤0.01%	1577
2017 Q1	$25.9M	Buy	+475,058	New	+$23.4M	0.01%	1531

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Bank of America's BIVV Position: Q1 2018 in Review

Bank of America sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 452,808 shares — an estimated $24.4M sold.

Bank of America first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $29.9M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Bank of America reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Bank of America sold 452,808 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $24.4M.
Bank of America first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Bank of America's Bioverativ Inc. Common Stock position peaked at $29.9M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.